Trial reportSultan Qaboos University medical journal2025
Effect of Prophylactic Tranexamic Acid on Peripartum Changes in Haemoglobin Concentration After Vaginal Delivery.
Trial report in Sultan Qaboos University medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the effect of prophylactic intravenous tranexamic acid on postpartum haemoglobin (Hb) concentration values compared to a control group. Methods: This randomised controlled study took place from May to July 2023 and included parturients with no apparent risk for postpartum haemorrhage from the University of Calabar Teaching Hospital in Calabar, Nigeria. Participants were divided equally into 2 groups. Group A (intervention group) received 10 IU of intramuscular oxytocin along with 1,000 mg of intravenous tranexamic acid within 1 minute of vaginal delivery, while Group B (control group) received 10 IU of intramuscular oxytocin with 10 mL of sterile water. The primary outcome measure was the difference in admission and postpartum Hb concentration. Results: A total of 80 parturients were included in this study; 40 were allocated to each study arm. The demographic characteristics and admission parameters of the 2 groups showed no significant statistical difference ( Conclusions: Compared to the placebo plus oxytocin, tranexamic acid plus oxytocin exhibited effectiveness in reducing postpartum Hb drop after vaginal delivery. Therefore, the use of tranexamic acid plus oxytocin is recommended as part of the active management of the third stage of labour.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.